AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

HIV Policy & Programs

Dr. Carl Dieffenbach: IAS Conference Highlights HIV Treatment Advances – Day 4

7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), Kuala Lumpur, Malaysia.

Today was the final day of the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID, to share daily dispatches from this important scientific conference via Skype. As Dr. Dieffenbach related, research related to significant HIV treatment advances has been a major…

Dr. Carl Dieffenbach: 7th International AIDS Society (IAS) Conference Addresses Social Determinants of Health – Day 3

IAS 2013

Yesterday, July 2, was the second full day of the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID to share daily highlights from this important scientific conference via Skype. As Dr. Dieffenbach shared, researchers at the conference discussed the social determinants of…

Dr. Carl Dieffenbach: 7th International AIDS Society (IAS) Conference Highlights Value of Treatment Cascade – Day 2

IAS Day 2

Yesterday, July 1, was the first full day of the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia—the world’s largest scientific conference on HIV/AIDS. This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID, to share daily highlights from the conference via Skype. Dr. Dieffenbach relayed that one of the themes…

Highlights from the 7th International AIDS Society (IAS) Conference Opening Session

International AIDS Society Day 1

June 30, 2013, was the opening plenary of the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. We asked Dr. Carl Dieffenbach, Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID), to share highlights from the conference via Skype. Please…

FDA approves first genotyping test for patients with hepatitis C virus

FDA

The U.S. Food and Drug Administration today approved a test that identifies the genotype of hepatitis C virus (HCV) that a patient is carrying. The Abbott RealTime HCV Genotype II, which can differentiate genotypes 1, 1a, 1b, 2, 3, 4, and 5,using a sample of an infected patient’s blood plasma or serum, will aid health…

AIDSVu Maps Depict Impact of HIV in America

AIDSVu 2013

Yesterday, National HIV Testing Day, marked the third annual update to AIDSVu , an interactive online tool that maps the HIV epidemic across the United States. A project of the Rollins School of Public Health at Emory University, AIDSVu displays HIV prevalence data at the national, state and local levels and by different demographics, including age,…

Take the Test and Take Control: National HIV Testing Day

SAMHSA logo

Take control of your health and observe the nineteenth annual National HIV Testing Day (NHTD) by taking an HIV test.  The 2013 NHTD theme, “Take the Test and Take Control,” promotes the importance of HIV testing in detecting, treating, and preventing human immunodeficiency virus (HIV) infection.  CDC reported that, since the mid-1990’s, the number of…

Advances in HIV Testing

NHTD160120

Today is the 19th annual National HIV Testing Day (NHTD). HIV testing is the first critical step to ending the HIV epidemic in the United States, and testing and linkage to care continue to be the mainstay of our prevention efforts at the Center for Disease Control and Prevention. HIV testing is the only way…